Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 74,300 | 40,700 | 153,200 | 98,200 | 76,300 |
| Depreciation Amortization | 115,100 | 57,000 | 221,800 | 164,700 | 110,700 |
| Income taxes - deferred | -4,600 | -4,200 | -10,900 | -22,500 | -12,800 |
| Accounts receivable | 101,200 | 109,800 | -19,000 | 85,300 | 63,800 |
| Accounts payable and accrued liabilities | -40,200 | -58,100 | 63,100 | -58,400 | 39,300 |
| Other Working Capital | 14,900 | 61,100 | 35,500 | -59,700 | 95,800 |
| Other Operating Activity | -21,900 | -25,500 | -9,300 | 9,100 | -83,500 |
| Operating Cash Flow | $238,800 | $180,800 | $434,400 | $216,700 | $289,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88,100 | -29,800 | -173,700 | -117,500 | -71,100 |
| Net Acquisitions | -4,700 | -700 | -9,600 | -9,600 | -300 |
| Sale Of Investment | 3,600 | 3,600 | N/A | 0 | 0 |
| Investing Cash Flow | $-89,200 | $-26,900 | $-183,300 | $-127,100 | $-71,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 958,500 | N/A | 963,300 | 963,300 | 963,300 |
| Debt Issued | -10,000 | -6,900 | -23,300 | -16,300 | -9,600 |
| Dividend Paid | -69,900 | -35,400 | -139,100 | -104,700 | -70,200 |
| Other Financing Activity | -959,700 | -3,200 | -979,500 | -979,400 | -981,100 |
| Financing Cash Flow | $-81,100 | $-45,500 | $-178,600 | $-137,100 | $-97,600 |
| Beginning Cash Position | 219,600 | 219,600 | 147,100 | 147,100 | 147,100 |
| End Cash Position | 288,100 | 328,000 | 219,600 | 99,600 | 267,700 |
| Net Cash Flow | $68,500 | $108,400 | $72,500 | $-47,500 | $120,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 238,800 | 180,800 | 434,400 | 216,700 | 289,600 |
| Capital Expenditure | -89,400 | -31,100 | -185,700 | -126,200 | -71,100 |
| Free Cash Flow | 149,400 | 149,700 | 248,700 | 90,500 | 218,500 |